Navigation Links
Illinois Radiologists Self-Edit Reports, Reduce Turnaround Time with SpeechQ for Radiology(TM)
Date:3/19/2008

of phone calls from physicians' offices requesting reports."

Powered by the Philips SpeechMagic(TM) speech engine, SpeechQ for Radiology integrates with most radiology-specific information systems and PACS, and was rated number one for front-end speech recognition by its customers in the KLAS 2006 and 2007 Enterprise Speech Recognition Reports.

"The most important results of this front-end speech recognition solution are being recognized by the patients and their physicians," says Scott Bennett, MedQuist senior vice president of Sales and Marketing. "Because Provena Mercy is using a technology that allows the radiologists to quickly create their diagnostic reports and put them in the hands of a patient's physician, the patient is treated faster, and that treatment is based on a complete and final diagnostic report."

About Provena Mercy

Provena Mercy Medical Center is a 356-bed hospital located in the Chicago suburb of Aurora, Illinois. This community-based hospital has a well-earned reputation as a proponent of leading-edge technologies, coupled with a commitment to patient comfort and exceptional patient care. Provena Mercy has received many awards for excellence, including being ranked among the nation's top 10 percent of hospitals for orthopedic services, and recently being awarded a five-star rating by HealthGrades(TM) for cardiovascular services. Provena Mercy is part of Provena Health, a Catholic health system that includes six hospitals, 14 long-term care and senior residential facilities, and over 40 clinics in Illinois and Indiana.

About MedQuist

MedQuist is the largest Medical Transcription Service Organization (MTSO) in the world, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, incre
'/>"/>

SOURCE MedQuist, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. New Case Study Details How an Illinois Hospital Created a Safe Lifting Team that Dramatically Reduced Injuries, Increased Staff Satisfaction
3. AmerisourceBergen Technology Group Opens New Facility in Buffalo Grove, Illinois
4. Gov. Blagojevich Signs Bill Improving Illinois Mental Illness Treatment Law
5. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
6. Illinois AARP Presses for Expansion of Childrens Health Insurance Program (SCHIP)
7. Y-ME Illinois Hosts the First-Ever BIG Night Out - Indulgence for a Cause
8. Doctors of Optometry Applaud New Law Requiring Eye Exams for Illinois Children
9. Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion
10. Marianjoy Rehabilitation Hospital to Receive James Brady Award From Brain Injury Association of Illinois
11. Haughton-Pitts Joins AARP Illinois Executive Council
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets 2Health News:Barr Confirms Patent Challenge of Xyzal(R), 5mg Tablets 3Health News:Pill Could Boost Sports Performance 2Health News:Get Straight A's in Snacking with Supercharged Superfruits from Fruitaceuticals! 2Health News:'Who's Who' Weight Specialist Martin Schiff, M.D., 86, Devoting Rest of Life to Spreading Truth About Diets, Won't Accept Compensation From Anyone, Sending Complete Guide Free to All 2Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 2Health News:Liver damage in hepatitis C patients could be treated with warfarin, says study 3Health News: Freescale and Monebo Launch ECG-on-a-Chip Platform Solution to Aid Heart Monitoring : Advanced Hardware and Software Technology Designed to Enable More Efficient and Higher Quality Cardiac Care 2
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 1Autism Support Network Launches Enhanced Features Adds Thousands of New Members Globally 57318 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 1Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 2Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 3Video 3A Teen Girls Less Active but Triple Play Program Bucks Trend 57317 4Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 1Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz Lamivudine and Tenofovir Disoproxil Fumarate Tablets 57314 2
Other Medicine Technology:Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 2Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 3Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 4Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 5Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months 6Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 2Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 3Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 4Poniard Pharmaceuticals' Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial 5